This activity is designed to engage your critical thinking about patients who may have alpha-1 antityrypsin deficiency (AATD) and to challenge suboptimal approaches to the management of patients with AATD lung disease. You will hear unique insights from 3 clinical experts and a patient living with AATD during this dynamic presentation.
Upon successful completion of this education activity, participants should be better able to:
Director , Alpha-1 Program
Division of Pulmonary, Critical Care, and Sleep Medicine
National Jewish Health
Featured RMEI CE Activities